Identifying chemotherapy beneficiaries in nasal and paranasal sinus cancers: epidemiological trends and machine learning insights.

Journal: European journal of medical research
PMID:

Abstract

BACKGROUND: Studies on the epidemiological characteristics, treatment strategies and prognosis of nasal and paranasal sinus cancer are still relatively limited.

Authors

  • Zihan Chen
    School of Data Science, University of Science and Technology of China, Hefei, PR China.
  • Zongwei Huang
    Department of General Surgery, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
  • Yuhui Pan
    Donnelly Centre for Cellular and Biomolecular Research, Department of Molecular Genetics and Department of Computer Science at University of Toronto, Toronto, ON M5S 3E2, Canada.
  • Youliang Weng
    Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fujian Branch of Fudan University Shanghai Cancer Center, Fuzhou 350014, PR China.
  • Zijie Wu
    Department Radiation oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou, 350014, Fujian, China.
  • Jing Wang
    Endoscopy Center, Peking University Cancer Hospital and Institute, Beijing, China.
  • Wenxi Wu
    Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital(Fujian Branch of Fudan University Shanghai Cancer Center), 420 Fuma Rd, Jin'an District, Fuzhou, Fujian, China.
  • Xinyi Hong
    Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou, Fujian, China.
  • Xin Chen
    University of Nottingham, Nottingham, United Kingdom.
  • Sufang Qiu